Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09ALE
|
||||
| Former ID |
DIB004159
|
||||
| Drug Name |
Enadoline
|
||||
| Synonyms |
Enadoline hydrochloride; PD-129290
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
Parke-Davis & Co
|
||||
| Formula |
C24H32N2O3
|
||||
| InChIKey |
JMBYBVLCYODBJQ-HFMPRLQTSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Kappa-type opioid receptor | Target Info | Agonist | [525469] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| References | |||||
| Ref 525469 | Enadoline, a selective kappa-opioid receptor agonist shows potent antihyperalgesic and antiallodynic actions in a rat model of surgical pain. Pain. 1999 Mar;80(1-2):383-9. | ||||
| Ref 539017 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1646). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.